According to the Joi + Blokes GLP-1 page, the most common side effects reported with semaglutide and tirzepatide include nausea, vomiting, diarrhea, constipation, bloating or gas, decreased appetite, and fatigue
Standard therapy may reduce nerve excitability, but pain can persist if mechanical irritation, inflammation, local nerve injury, muscle spasm, metabolic factors, or central sensitization are not addressed together
Product Specifications Research Overview IGF-1 LR3, written in the primary literature as Long-[Arg3]-IGF-I or LR3IGF-I, is an 83 residue recombinant analogue of human insulin-like growth factor 1
(2024) 327:H370h6